Camber Spine is offering SCYLLA, an allogeneic bone matrix product containing viable spine-derived cells that is complementary to its SPIRA® and ENZA® spinal fusion devices.
Globus Medical (GMED) acquired StelKast, manufacturer of implants and instruments for hip and knee replacement, for USD $24.1MM in cash plus potentially $4.3MM in product sales milestones. GMED plans to release a robotic system for joint reconstruction in late 2020.
LimaCorporate completed an agreement to distribute G21's SpaceFlex Cement Spacer portfolio in the European Economic Area, Switzerland, Australia and New Zealand markets.